Close

Cipher Pharma's (CPHR) Dermadexin and Pruridexin Approved in Canada

April 6, 2016 4:03 PM EDT Send to a Friend
Cipher Pharmaceuticals Inc. (NASDAQ: CPHR) announced it has received Health Canada approvals for SD Cream and AD Cream (also known ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login